Naratriptan and Ondansetron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Naratriptan (naratriptan) and Ondansetron (ondansetron). Common drug interactions include fatigue among females and adverse event among males.

The phase IV clinical study analyzes what interactions people have when they take Naratriptan and Ondansetron. It is created by eHealthMe based on reports of 95 people who take the same drugs from the FDA, and is updated regularly.

What is Naratriptan?

Naratriptan has active ingredients of naratriptan. It is often used in migraine. eHealthMe is studying from 1,481 Naratriptan users. Check the latest studies of Naratriptan.

What is Ondansetron?

Ondansetron has active ingredients of ondansetron. It is often used in nausea. eHealthMe is studying from 122,738 Ondansetron users. Check the latest studies of Ondansetron.

On Jul, 27, 2026

95 people who take Naratriptan and Ondansetron together, and have interactions are studied.

Naratriptan and Ondansetron drug interactions.

What are the common drug interactions of Naratriptan and Ondansetron, by gender? *:

female:

Fatigue (feeling of tiredness)
Dystonia (abnormal muscle tone)
Fall
Myalgia (muscle pain)
Opisthotonus (a condition in which the body is held in an abnormal position)
Rash
Emotional distress
Anxiety
Chronic kidney disease
Drug ineffective

male:

Adverse event
Chest pain
Rhinorrhoea (watery mucus discharge from the nose)
Chills (felling of cold)
Dizziness
Headache (pain in head)
Herpes zoster
Muscle spasms (muscle contraction)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Oropharyngeal pain

What are the common drug interactions of Naratriptan and Ondansetron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Papilloedema (optic disc swelling)

20-29:

Blindness transient (sudden loss of vision)
Eyelid ptosis (falling of the upper or lower eyelid)
Facial pain
Facial paralysis (loss of function of face muscle)
Headache (pain in head)
Hypersensitivity
Injection site pruritus (severe itching at injection site)
Swelling face
Vision blurred

30-39:

Headache (pain in head)
Fatigue (feeling of tiredness)
Rash
Weight increased
Abdominal pain
Alopecia (absence of hair from areas of the body)
Anxiety
Blood potassium decreased
Breakthrough pain
Breast disorder

40-49:

Insomnia (sleeplessness)
Logorrhoea (excessive, uncontrollable, or incoherent talkativeness)
Mass
Muscle spasticity (tight or stiff muscles and an inability to control those muscles)
Neck pain
Pain
Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Arthralgia (joint pain)
Balance disorder

50-59:

Fatigue (feeling of tiredness)
Kidney infection
Nephrolithiasis (calculi in the kidneys)
Arthralgia (joint pain)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
C-reactive protein increased
Dizziness
Drug ineffective
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Hypertension (high blood pressure)

60+:

Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Chronic kidney disease
Dizziness
Fall
Fibromyalgia (a long-term condition which causes pain all over the body)
Gastritis (inflammation of stomach)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Infection
Irritable bowel syndrome
Lip disorder (disease of lip)

What are the existing conditions these people have? *

Pain: 19 people, 20.00%
Depression: 18 people, 18.95%
Stress And Anxiety: 9 people, 9.47%
Anaesthesia: 8 people, 8.42%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 7 people, 7.37%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 7.37%
Asthma: 7 people, 7.37%
Immunodeficiency Common Variable: 6 people, 6.32%
Psoriasis (immune-mediated disease that affects the skin): 5 people, 5.26%
High Blood Cholesterol: 5 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Naratriptan and Ondansetron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously